SCHEMBL12481908

SCHEMBL12481908

CN(Cc1ccc(C=O)c(Cl)c1)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.43
RAB9A P51151 4/20 0.43
ALDH1A1 P00352 3/20 0.43
HTT P42858 2/20 0.43
HSP90AA1 P07900 3/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 3/20 0.39
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
AOC3 Q16853 1/20 0.39
ERCC1 P07992 1/20 0.39
ERCC4 Q92889 1/20 0.39
USP30 Q70CQ3 1/20 0.38
HPGD P15428 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4704482 0.88 MEN1 (0.44) RAB9AALDH1A1HTTHSP90AA1MEN1
SCHEMBL8754543 0.82 PYCR1 (0.50) RAB9AALDH1A1HTTHSP90AA1MEN1
SCHEMBL15424207 0.81 HTR2C (0.40) TDP1RAB9AALDH1A1HTTHSP90AA1
SCHEMBL12480587 0.78 MAOB (0.45) RAB9AALDH1A1HTTHSP90AA1MEN1
SCHEMBL663543 0.76 ALDH1A1 (0.48) RAB9AALDH1A1HTTHSP90AA1MEN1
SCHEMBL3451226 0.76 CA2 (0.61) TDP1ALDH1A1HTTMEN1KMT2A
SCHEMBL1935709 0.75 RAB9A (0.47) RAB9AALDH1A1HTTMEN1KMT2A
SCHEMBL5260772 0.75 MEN1 (0.46) RAB9AALDH1A1HTTHSP90AA1MEN1
SCHEMBL4700343 0.74 CDK8 (0.43) ALDH1A1MEN1KMT2AMAPT
SCHEMBL7161146 0.73 TDP1 (0.55) TDP1ALDH1A1HTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3321261-B1 HEDGEHOG ANTAGONISTS HAVING ZINC BINDING MOIETIES CURIS INC (US) 2020-06-17 EP disclosed
EP-3321261-A1 HEDGEHOG ANTAGONISTS HAVING ZINC BINDING MOIETIES Curis, Inc. (US) 2018-05-16 EP disclosed
EP-2661425-B1 HEDGEHOG ANTAGONISTS HAVING ZINC BINDING MOIETIES CURIS INC (US) 2018-02-28 EP disclosed
US-20170349573-A1 HEDGEHOG ANTAGONISTS HAVING ZINC BINDING MOIETIES CURIS INC (US) 2017-12-07 US disclosed
US-9708299-B2 Hedgehog antagonists having zinc binding moieties GENENTECH, INC. (US) 2017-07-18 US disclosed
US-20140018368-A1 HEDGEHOG ANTAGONISTS HAVING ZINC BINDING MOIETIES GENETECH, INC. (US) 2014-01-16 US disclosed
EP-2661425-A2 HEDGEHOG ANTAGONISTS HAVING ZINC BINDING MOIETIES Curis, Inc. (US) 2013-11-13 EP disclosed
WO-2012094328-A2 HEDGEHOG ANTAGONISTS HAVING ZINC BINDING MOIETIES CURIS, INC. (US) 2012-07-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349573-A1 HEDGEHOG ANTAGONISTS HAVING ZINC BINDING MOIETIES GLI1, SHH, HDAC1 TDP1 4519/4885RAB9A 2113/4885ALDH1A1 1006/4885
US-20140018368-A1 HEDGEHOG ANTAGONISTS HAVING ZINC BINDING MOIETIES GLI1, SHH, HDAC1 TDP1 4519/4885RAB9A 2113/4885ALDH1A1 1006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.